Selumetinib is a prescription medication used to treat certain types of cancer, including advanced thyroid cancer, neurofibromatosis type 1-related malignant peripheral nerve sheath tumors, and non-small cell lung cancer. It is a type of targeted therapy that works by blocking the activity of certain proteins called MEK enzymes, which are involved in cell growth. Selumetinib is taken as a pill twice daily. Common side effects include nausea, vomiting, skin rash, and fatigue.
Selumetinib (brand name: Koselugo®) is a medication used to treat specific types of cancer by targeting their growth pathways [1, 2]. Here's a breakdown of its key aspects:
Type of Drug:
- Selumetinib is a targeted therapy drug classified as a MEK inhibitor [1]. MEK stands for Mitogen-activated protein kinase kinase, an enzyme involved in a signaling pathway that promotes cell growth and division.
How it Works:
- Cancer cells often have mutations that activate this MEK pathway, leading to uncontrolled cell growth. Selumetinib works by blocking the activity of MEK, thereby interrupting this growth signal and hindering cancer cell proliferation [1, 2].
Conditions Treated:
Selumetinib is approved for the treatment of adults with specific mutations in the following cancers:
- Melanoma: A type of skin cancer that can spread to other parts of the body if not treated early [1]. This is for cases where the melanoma has a BRAF V600E or V600K mutation.
- Neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas: These are benign (non-cancerous) tumors that arise from nerve tissues in people with NF1, a genetic disorder [2].
Benefits:
- In melanoma, Selumetinib, used in combination with another medication called dabrafenib, can help shrink tumors and improve progression-free survival (time without the disease worsening) compared to treatment with only one medication [1].
- For plexiform neurofibromas, Selumetinib can help reduce tumor size and alleviate symptoms such as pain or disfigurement [2].
Dosage and Administration:
- Selumetinib comes in capsules taken orally, typically twice daily with or without food [1].
- The exact dosage depends on factors like the specific condition being treated and your overall health.
Side Effects:
- Common side effects of Selumetinib can include [1, 2]:
- Skin rash (acne-like)
- Diarrhea
- Fatigue
- Nausea
- Joint pain
- Fever
- Hair loss
Important Considerations:
- Selumetinib is a targeted therapy, and its effectiveness depends on the presence of specific mutations. Genetic testing is required to determine if you have a BRAF V600E/K mutation in melanoma or an NF1 mutation for plexiform neurofibromas [1, 2].
- It can interact with other medications, so it's crucial to disclose your full medication list to your doctor before starting Selumetinib.
- Selumetinib may not be suitable for everyone and can cause serious side effects. It's essential to discuss the potential risks and benefits with your doctor.
- Pregnant or breastfeeding women should not take Selumetinib due to potential risks to the developing baby [1].
If you have melanoma or plexiform neurofibromas, talk to your doctor about whether genetic testing is appropriate to determine if Selumetinib might be a treatment option for you.
Here are some additional points to note:
- Selumetinib is a relatively established medication, but research continues to explore its use in other cancer types [2].
- Other treatment options exist for melanoma and plexiform neurofibromas, and your doctor will recommend the most suitable approach based on your specific situation, genetic profile, and overall health.